News

Comac Medical presents newly available data of successfully completed clinical trials at AASLD The Liver Meeting

We are happy to share that Comac Medical has been assigned with conducting Phase 2 randomized, placebo-controlled GULLIVER-2 trial. The results of the study were presented at AASLD The Liver Meeting on 4th-8th November.
Check the results in the following document.

Share:
Planning a clinical trial comes with numerous challenges, requiring a methodical approach for successful execution. However, unforeseen issues...
Abstract: In this prospective study, we assessed biomarkers of inflammation (IL-6 and SAA) from the serum of 120...
Landmark Changes Position Company for Continued Growth and Innovation Sofia, December 6, 2023 – Comac Medical, a leading...